### Diagnostics channel feed [Grail’s cancer blood test still isn’t ready for widespread use, experts say](https://endpoints.news/asco26-grails-cancer-blood-test-isnt-ready-for-widespread-use-experts-say/ "Grail’s cancer blood test still isn’t ready for widespread use, experts say") ### Grail’s can­cer blood test still isn’t ready for wide­spread use, ex­perts say 3 weeks ago [Grail names new CEO as Bob Ragusa retires](https://endpoints.news/grail-names-new-ceo-as-bob-ragusa-retires/ "Grail names new CEO as Bob Ragusa retires") ### Grail names new CEO as Bob Ra­gusa re­tires 3 months ago [The $100 genome, both a scientific milestone and marketing tool, is here](https://endpoints.news/roche-element-and-ultima-push-toward-the-100-genome/ "The $100 genome, both a scientific milestone and marketing tool, is here") ### The $100 genome, both a sci­en­tif­ic mile­stone and mar­ket­ing tool, is here 3 months ago [Why did my doctor push Grail’s dubious cancer test?](https://endpoints.news/why-did-my-doctor-push-grails-dubious-cancer-test/ "Why did my doctor push Grail’s dubious cancer test?") ### Why did my doc­tor push Grail’s du­bi­ous can­cer test? 3 months ago [China's MGI sells US subsidiary Complete Genomics after Biosecure Act stalled ambitions](https://endpoints.news/swiss-rockets-buys-mgi-subsidiary-complete-genomics-after-biosecure-act/ "China's MGI sells US subsidiary Complete Genomics after Biosecure Act stalled ambitions") ### Chi­na's MGI sells US sub­sidiary Com­plete Ge­nomics af­ter Biose­cure Act stalled am­bi­tions 3 months ago [After rallying, Grail's cancer test faces new uncertainty due to UK study](https://endpoints.news/grails-cancer-test-faces-new-uncertainty-after-uk-study/ "After rallying, Grail's cancer test faces new uncertainty due to UK study") ### Af­ter ral­ly­ing, Grail's can­cer test faces new un­cer­tain­ty due to UK study 3 months ago [Grail's cancer test shows promise, but misses primary goal in UK study](https://endpoints.news/grails-cancer-test-misses-primary-study-goal-in-uk-study/ "Grail's cancer test shows promise, but misses primary goal in UK study") ### Grail's can­cer test shows promise, but miss­es pri­ma­ry goal in UK study 3 months ago [Illumina bets on healthcare customers after NIH funding disruptions](https://endpoints.news/illumina-bets-on-healthcare-after-trump-administrations-nih-funding-disruptions/ "Illumina bets on healthcare customers after NIH funding disruptions") ### Il­lu­mi­na bets on health­care cus­tomers af­ter NIH fund­ing dis­rup­tions 4 months ago [Hims adds Grail's cancer test amid questions about widespread use](https://endpoints.news/hims-adds-grails-cancer-test-amid-questions-about-widespread-use/ "Hims adds Grail's cancer test amid questions about widespread use") ### Hims adds Grail's can­cer test amid ques­tions about wide­spread use 4 months ago [Exclusive: Cellens raises $6.5M to advance physics-based test for bladder cancer](https://endpoints.news/labcorp-backs-cellens-in-developing-physics-test-aimed-at-bladder-cancer/ "Exclusive: Cellens raises $6.5M to advance physics-based test for bladder cancer") ### Ex­clu­sive: Cel­lens rais­es $6.5M to ad­vance physics-based test for blad­der can­cer 5 months ago [Hims launches lab testing for preventive care](https://endpoints.news/hims-launches-lab-testing-for-preventive-care/ "Hims launches lab testing for preventive care") ### Hims launch­es lab test­ing for pre­ven­tive care 7 months ago [Exclusive: Ex-Illumina and Grail employees raise $6.7M to spot liver disease](https://endpoints.news/hepta-raises-6-7m-to-take-liquid-biopsy-into-liver-disease/ "Exclusive: Ex-Illumina and Grail employees raise $6.7M to spot liver disease") ### Ex­clu­sive: Ex-Il­lu­mi­na and Grail em­ploy­ees raise $6.7M to spot liv­er dis­ease 7 months ago [10x Genomics sues DNA giant Illumina over patents](https://endpoints.news/10x-genomics-files-patent-suits-against-illumina/ "10x Genomics sues DNA giant Illumina over patents") ### 10x Ge­nomics sues DNA gi­ant Il­lu­mi­na over patents 7 months ago [After financial troubles, Grail raises $325M from Hims and others](https://endpoints.news/grail-raises-325m-from-hims-and-others-ahead-of-fda-bid/ "After financial troubles, Grail raises $325M from Hims and others") ### Af­ter fi­nan­cial trou­bles, Grail rais­es $325M from Hims and oth­ers 7 months ago [Grail reports fewer false alarms for blood cancer test ahead of FDA filing](https://endpoints.news/grails-cancer-test-better-at-spotting-real-cases-as-fda-filing-nears/ "Grail reports fewer false alarms for blood cancer test ahead of FDA filing") ### Grail re­ports few­er false alarms for blood can­cer test ahead of FDA fil­ing 8 months ago [British startup Genomics launches business to help drug developers](https://endpoints.news/british-startup-genomics-launches-business-to-help-drug-developers/ "British startup Genomics launches business to help drug developers") ### British start­up Ge­nomics launch­es busi­ness to help drug de­vel­op­ers 8 months ago [A new use for a very old drug: Aspirin cut risk of recurrence for some types of colorectal cancer in half](https://endpoints.news/a-new-use-for-a-very-old-drug-aspirin-cut-risk-of-recurrence-for-some-types-of-colorectal-cancer-in-half/ "A new use for a very old drug: Aspirin cut risk of recurrence for some types of colorectal cancer in half") ### A new use for a very old drug: As­pirin cut risk of re­cur­rence for some types of col­orec­tal can­cer in half 9 months ago [A former NIH director reflects on genomic medicine and political 'decapitation'](https://endpoints.news/eric-green-who-the-trump-administration-ousted-from-nih-urges-optimism/ "A former NIH director reflects on genomic medicine and political 'decapitation'") ### A for­mer NIH di­rec­tor re­flects on ge­nom­ic med­i­cine and po­lit­i­cal 'de­cap­i­ta­tion' 9 months ago [Labcorp drums up competition for health testing startups](https://endpoints.news/labcorp-drums-up-competition-for-health-testing-startups/ "Labcorp drums up competition for health testing startups") ### Lab­corp drums up com­pe­ti­tion for health test­ing star­tups 11 months ago [The Trump administration disbanded a newborn screening panel. Advocates now face a harder path](https://endpoints.news/the-trump-administration-disbanded-a-federal-newborn-screening-panel-advocates-now-face-a-harder-path/ "The Trump administration disbanded a newborn screening panel. Advocates now face a harder path") ### The Trump ad­min­is­tra­tion dis­band­ed a new­born screen­ing pan­el. Ad­vo­cates now face a hard­er path 11 months ago [Aqtual raises $31M to guide rheumatoid arthritis treatments](https://endpoints.news/aqtual-raises-31m-to-guide-rheumatoid-arthritis-treatments/ "Aqtual raises $31M to guide rheumatoid arthritis treatments") ### Aq­tu­al rais­es $31M to guide rheuma­toid arthri­tis treat­ments 11 months ago [Quanterix closes Akoya deal after competing bid](https://endpoints.news/quanterix-closes-127m-akoya-deal-after-competing-bid/ "Quanterix closes Akoya deal after competing bid") ### Quan­ter­ix clos­es Akoya deal af­ter com­pet­ing bid 11 months ago [Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics](https://endpoints.news/illumina-to-buy-somalogic-for-350m-pushing-further-into-proteomics/ "Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics") ### Il­lu­mi­na to buy So­ma­Log­ic for $350M up­front, push­ing fur­ther in­to pro­teomics 11 months ago [Grail shares jump on study results for cancer test](https://endpoints.news/grail-shares-jump-on-study-results-for-cancer-test/ "Grail shares jump on study results for cancer test") ### Grail shares jump on study re­sults for can­cer test 12 months ago